Canopy Growth CGC
NASDAQ CGC
$1.03 0.00 (-0.48%)
At close: Aug 20, 2026 · 1:00 PM UTC

Canopy Growth (CGC) Cash & Current Investments (2017 - 2026)

Canopy Growth (CGC) posted Cash & Current Investments of $265.9 million for Q1 2026, little changed sequentially from $266.3 million in Q4 2025, and up 190.25% YoY from $91.6 million in Q1 2025.

Canopy Growth (CGC) Cash & Current Investments (2017 - 2026) Analysis & Trends

Canopy Growth has reported Cash & Current Investments for 10 years, with the latest figure at $265.9 million in Q1 2026.

  • Quarterly Cash & Current Investments rose 190.25% year-over-year to $265.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $265.9 million (up 190.25% YoY) and the FY2026 annual result came in at $265.9 million, up 190.25% from the prior year.
  • Cash & Current Investments steadied at $265.9 million in Q1 2026 per CGC's latest filing, from $266.3 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $1.1 billion in Q1 2022 and troughed at $91.6 million in Q1 2025.
  • A 5-year average of $354.6 million and a median of $187.2 million in 2023 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2023 and 2026: Cash & Current Investments slumped 78.65% in 2023, then soared 190.25% in 2026.
  • Over 5 years, Cash & Current Investments stood at $581.4 million in 2022, then tumbled by 76.48% to $136.8 million in 2023, then declined by 6.65% to $127.7 million in 2024, then jumped by 108.57% to $266.3 million in 2025, then retreated by 0.13% to $265.9 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $265.9 million, $266.3 million, and $94.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 43.96 Bn 43.00 Bn - 963.33 Mn
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn 3.66 Bn
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn 1.68 Bn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn 5.80 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 2.66 Bn
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn 886.50 Mn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn 389.80 Mn
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn 530.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - 164.00 Mn
10 Canopy Growth 434.93 Mn 187.92 Mn 16.08 Mn 247.01 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 247.01 Mn
Mar 31, 2026 265.93 Mn
Dec 31, 2025 266.27 Mn
Sep 30, 2025 94.07 Mn
Jun 30, 2025 95.29 Mn
Mar 31, 2025 91.62 Mn
Dec 31, 2024 127.67 Mn
Sep 30, 2024 172.93 Mn
Jun 30, 2024 146.12 Mn
Mar 31, 2024 131.81 Mn
Dec 31, 2023 136.76 Mn
Sep 30, 2023 187.20 Mn
Jun 30, 2023 403.79 Mn
Mar 31, 2023 413.25 Mn
Dec 31, 2022 581.44 Mn
Sep 30, 2022 876.71 Mn
Jun 30, 2022 954.63 Mn
Mar 31, 2022 1.08 Bn
Dec 31, 2021 1.13 Bn
Sep 30, 2021 651.29 Mn